K29* (p.Lys29Ter) variant of TTR (Transthyretin)

K29* (p.Lys29Ter) in TTR (Transthyretin) is a protein-truncating change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.69 / 1. The record also includes population frequency data and structural context.

K29* (p.Lys29Ter) variant details